Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Clora is an intelligent platform that matches life science companies with flexible, on-demand expertise.
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
Mission Barns is making the juicy, savory meats they all love in a sustainable, more efficient way.
Phenomic AI is a developer of a drug discovery platform designed to discovery and optimize therapeutics directly against phenotypic assays.
Clara Health empowers patients to find the right clinical trial for them.
The complete platform for interacting with 3D data
Collider makes a machine that makes parts in off-the-shelf manufacturing materials using 3D printed tooling and an injection process.
Cantos has invested in 55 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Cantos's top investment sectors include Biotechnology, Life Science, Pharmaceutical, Therapeutics, Software. The firm invests across 25 different industry categories.
Among tracked funding rounds, Mission Barns received $24.0M in a Series A round. Cantos's total known invested capital is $663.7M.
Cantos's average investment size is $16.2M across its portfolio of 55 companies.
Recent Cantos portfolio additions include Clora, Sixfold Bioscience, Mission Barns, Phenomic AI, Clara Health. These companies were founded in 2020 or later.